Recent Finacing
Recent Raise
Gliknik is a Baltimore-based biopharma developing Stradomer-based biologic immunotherapies for cancer and autoimmune diseases, including phase 2 immuno-oncology biropepimut-S and IVIG-mimetic GL-2045 (Pfizer-licensed).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Gliknik.
